Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Yoshiko, Azuma"'
Autor:
Minoru Shigesaka, Tomoki Ito, Muneo Inaba, Kai Imai, Hideki Yamanaka, Yoshiko Azuma, Akihiro Tanaka, Hideki Amuro, Tohru Nishizawa, Yonsu Son, Atsushi Satake, Yoshio Ozaki, Shosaku Nomura
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-11 (2020)
Abstract Background Both humoral and cellular immune mechanisms are involved in the onset and progression of autoimmune responses in systemic lupus erythematosus (SLE). Plasmacytoid dendritic cells (pDCs) play a central role in the pathogenesis of SL
Externí odkaz:
https://doaj.org/article/e81bcc18f79f45499484f4c1e8f8cccc
Autor:
Kazuyoshi Ishii, Aya Nakaya, Shinya Fujita, Atsushi Satake, Yoshiko Azuma, Yukie Tsubokura, Ryo Saito, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Tomoki Ito, Shosaku Nomura
Publikováno v:
Leukemia Research Reports, Vol 11, Iss , Pp 8-10 (2019)
A 49-year-old woman diagnosed with chronic myeloid leukemia in the chronic phase was started on dasatinib treatment, after which she complained of myodesopsia. Nineteen months after diagnosis, the patient again complained of myodesopsia and developed
Externí odkaz:
https://doaj.org/article/2893bd33829d4aafa75e9d5e58e31361
Autor:
Akiko Konishi, Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Ryo Saito, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
Publikováno v:
Leukemia Research Reports, Vol 11, Iss , Pp 11-13 (2019)
Background: Although eltrombopag has recently been approved for treating AA, the effects of its clinical use remain unknown. Methods: We retrospectively analyzed 11 patients with AA, who had been treated with eltrombopag from August 2017 to May 2018.
Externí odkaz:
https://doaj.org/article/423f9aaa529f479d90c1930d382f70f2
Autor:
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 871-875 (2017)
The survival of multiple myeloma patients has improved significantly over the last several decades. However, the median overall survival of these patients remains less than 5 years. In this report, we discuss 4 cases of multiple myeloma patients that
Externí odkaz:
https://doaj.org/article/761b0df44748467eb4a299cff582ef2a
Autor:
Tomoki Ito, Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Shosaku Nomura
Publikováno v:
Leukemia Research Reports, Vol 10, Iss , Pp 4-6 (2018)
Pure red cell aplasia (PRCA) is a rare disorder characterized by marked erythroid hypoplasia with maturation arrest in the bone marrow. Secondary acquired PRCA may be associated with hematologic disorders. A few case reports have described PRCA assoc
Externí odkaz:
https://doaj.org/article/e6295549c11f4db6843e357e16329f33
Autor:
Takahisa Nakanishi, Aya Nakaya, Yusuke Nishio, Shinya Fujita, Atsushi Satake, Yoshiko Azuma, Yukie Tsubokura, Ryo Saito, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Yoshihiko Kadosaka, Kazuyoshi Ishii, Tomoki Ito, Koji Tsuta, Shosaku Nomura
Publikováno v:
Hematology Reports, Vol 11, Iss 3 (2019)
A 63-year-old man was diagnosed with a rare variant of acute promyelocytic leukemia (APL) with t(4;17)(q12; q21) that showed atypical morphological features and two different clinical symptoms. He was started on standard induction chemotherapy for ac
Externí odkaz:
https://doaj.org/article/abff87a6395149948aa1be7ed0940ecf
Autor:
Yoshiko Azuma, Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yukie Tsubokura, Ryo Saito, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
Publikováno v:
Leukemia Research Reports, Vol 12, Iss , Pp - (2019)
Background: Neutrophil-to-lymphocyte ratio (NLR) has been recognized as a poor prognostic indicator in various solid tumors. Methods: We retrospectively analyzed 530 patients with de novo DLBCL who were diagnosed from April 2002 to November 2017. Res
Externí odkaz:
https://doaj.org/article/24e4db8c83f74df0b83100601abc427f
Autor:
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
Publikováno v:
Hematology Reports, Vol 10, Iss 3 (2018)
Dasatinib is currently approved for clinical use as a first-line treatment agent for newly diagnosed chronic myeloid leukemia (CML). However, only a few clinical trials have been performed to evaluate dasatinibinduced PE following first-line therapy.
Externí odkaz:
https://doaj.org/article/a26ca5eb12e247a6abe013d2cfc2a327
Autor:
Tomoki Ito, Akiko Konishi, Yukie Tsubokura, Yoshiko Azuma, Masaaki Hotta, Hideaki Yoshimura, Takahisa Nakanishi, Shinya Fujita, Aya Nakaya, Atsushi Satake, Kazuyoshi Ishii, Shosaku Nomura
Publikováno v:
Frontiers in Nutrition, Vol 5 (2018)
Lenalidomide is an immunomodulating derivative of thalidomide, which shows anti-tumor activity against myeloma cells with immunomodulation including augmentation of T-cell and natural killer cell function. Continuous treatment with this agent shows b
Externí odkaz:
https://doaj.org/article/cc604abea7284483b32067a50fa42a19
Autor:
Masaaki Hotta, Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Akiko Konishi, Hideaki Yoshimura, Tomoki Ito, Kazuyoshi Ishii, Shosaku Nomura
Publikováno v:
Hematology Reports, Vol 10, Iss 2 (2018)
Post-transplant lymphoproliferative disorder (PTLD) is a well-recognized complication of organ transplantation. Progress has recently been made in the pathological classification of PTLD. However, the clinical course has not been clarified because of
Externí odkaz:
https://doaj.org/article/486d026d548c4415af62e992010bbb0a